E
ESP Pharma
Discount worldwide pharmacy fulfillment service
About ESP Pharma
ESP Pharma is a Hong Kong-based company specializing in sourcing and delivering affordable brand name and generic medications from licensed and reputable pharmacies worldwide. The company serves cost-conscious consumers looking for quality pharmaceutical products at the lowest possible prices. Operating in the global pharmaceutical market, ESP Pharma collaborates with affiliate pharmacies to find the best deals on popular medications and passes these savings directly to customers. The business model revolves around sourcing medications from established pharmacies, ensuring quality and compliance, and then exporting these products by post to various countries. Revenue is generated through the sale of these medications, often at prices significantly lower than local pharmacies. The company guarantees delivery and customer satisfaction, providing free prescription consultations with all orders.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2005 | $475M | $475M | PDL Biopharma | — |
| SERIES B✓Equity / VC | Apr 2003 | $20M | $80M | NEA · Thoma Cressey Equity Partners · Domain Associates · Apax Partners | — |
Growth signals
Latest recorded traffic for ESP Pharma is 430 monthly website visits, up 43.3% over the last three months. ESP Pharma's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- TPThoma Cressey Equity Partners
NEA
Domain Associates
Apax Partners
Other known investors1 additional known investor
PDL Biopharma
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about ESP Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ESP Pharma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







